Prognostic factors in completely resected stage IB non-small cell lung cancer with a diameter of 4cm or more

被引：0
|
作者：
Okamoto, Junichi [1 ]
Hioki, Masafumi [2 ]
Kubokura, Hirotoshi [1 ,2 ]
Mikami, Iwao [1 ]
Hirata, Tomomi [1 ]
Haraguchi, Shuji [1 ]
Koizumi, Kiyoshi [1 ]
Shimizu, Kazuo [1 ]
机构：
[1] Nippon Med Sch, Tokyo 113, Japan
[2] Musashi Kosugi Hosp, Nippon Med Sch, Kawasaki, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S789 / S789
页数：1
相关论文
共 50 条
  • [21] Prognostic factors in resected Stage I and II non-small lung cancer (NSCLC)
    Mauro, Laura V.
    Dallurzo, Liliana
    Smith, David
    Veloso, Maria J.
    Lastiri, Jose
    Vasallo, Bartolome
    Pallotta, Maria G.
    de Kier Joffe, Elisa D. Bal
    Puricelli, Lydia
    CANCER RESEARCH, 2006, 66 (08)
  • [22] Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer
    Naim Younes, R.
    Gross, J. L.
    Abrao, F. C.
    Rodrigues Pereira, J.
    MINERVA CHIRURGICA, 2013, 68 (02) : 169 - 174
  • [23] Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
    Liang, Ying
    Wakelee, Heather A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 403 - 410
  • [24] A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
    Reiko Sakurai
    Yoshio Tomizawa
    Akihiro Yoshii
    Yosuke Miura
    Hiroaki Tsurumaki
    Kyoichi Kaira
    Noriaki Sunaga
    Osamu Kawashima
    Takeshi Hisada
    Masanobu Yamada
    Ryusei Saito
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 103 - 109
  • [25] A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
    Sakurai, Reiko
    Tomizawa, Yoshio
    Yoshii, Akihiro
    Miura, Yosuke
    Tsurumaki, Hiroaki
    Kaira, Kyoichi
    Sunaga, Noriaki
    Kawashima, Osamu
    Hisada, Takeshi
    Yamada, Masanobu
    Saito, Ryusei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 103 - 109
  • [26] A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment
    Shi, Chun-Lei
    Zhang, Xue-Yan
    Han, Bao-Hui
    He, Wei-Zhong
    Shen, Jie
    Chu, Tian-Qing
    MEDICAL ONCOLOGY, 2011, 28 (04) : 1441 - 1446
  • [27] A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment
    Chun-Lei Shi
    Xue-Yan Zhang
    Bao-Hui Han
    Wei-Zhong He
    Jie Shen
    Tian-Qing Chu
    Medical Oncology, 2011, 28 : 1441 - 1446
  • [28] Prognostic factors in stage I non-small cell lung cancer
    Thomas, P
    Barlesi, F
    Doddoli, C
    Pietri, P
    Astoul, P
    Giudicelli, R
    Fuentes, P
    New Advances in Thoracic Oncology: From Scientific Evidence to Optimal Management, 2005, 350 : 37 - 48
  • [29] Prognostic factors in stage I non-small cell lung cancer
    Passlick, B
    Pantel, K
    ZENTRALBLATT FUR CHIRURGIE, 1996, 121 (10): : 851 - 857
  • [30] A clinicopathological study of resected peripheral non-small cell lung cancer 2.0 cm or less in diameter
    Shi Chunlei
    Han Baohui
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S790 - S791
12345